Sacituzumab Tirumotecan in Previously Treated TROP2-Positive Advanced Biliary Tract Cancer

NCT07701122 · clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
33
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Collaborators